Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Florentia Sotsiou"'
Autor:
Dimitrios S. Goumenos, Florentia Sotsiou, F. Karagianni, Marios Papasotiriou, Miltiadis Gerolymos, A. Charonis, Pantelitsa Kalliakmani
Publikováno v:
Nephron Clinical Practice. 119:c74-c82
Background/Aims: Activation of myofibroblasts occurs during kidney injury. Genomic and proteomic studies suggest that transgelin represents a protein that may be involved in renal injury. The purpose of this study was to estimate transgelin expressio
Autor:
Florentia Sotsiou, John G. Vlachojannis, Pantelitsa Kalliakmani, Dimitrios S. Goumenos, Eleni Koutroulia
Publikováno v:
Nephrology. 15:762-767
Aim: Idiopathic membranous nephropathy (IMN), the most common cause of nephrotic syndrome in adults, is usually treated by cyclosporin A (CsA). Estimation of the effectiveness of long-term use of CsA in the remission and relapse rate of nephrotic syn
Autor:
Florentia Sotsiou, Dimitrios S. Goumenos, Athanassios C. Tsamandas, Dionysis S Bonikos, Sotiris Tsakas, John G. Vlachojannis, Pantelitsa Kalliakmani
Publikováno v:
Renal Failure. 26:361-367
Apoptosis, a gene-directed form of cell death, has been involved in the resolution of renal injury but also in the development of scarring. Bcl-2 and bax are proteins related to apoptotic process that either provides a survival advantage to rapidly p
Autor:
Florentia Sotsiou, John G. Vlachojannis, Pantelitsa Kalliakmani, S Tsakas, Dimitrios S. Goumenos
Publikováno v:
Clinical Nephrology. 61:17-24
BACKGROUND Idiopathic membranous nephropathy (IMN), a common cause of nephrotic syndrome in adults, is usually treated by combination of corticosteroids with cytotoxic drugs. In cases resistant to this regimen, the use of cyclosporin A (CsA) is follo
Autor:
Graham L. Thomas, Athanassios C. Tsamandas, Sotiris Tsakas, Dimitrios S. Goumenos, John G. Vlachojannis, Dionysis S Bonikos, Florentia Sotsiou, A. Meguid El Nahas
Publikováno v:
Nephron. 92:287-296
Background/Aims: The pathophysiological pathways involved in the pathogenesis and evolution of renal fibrosis, have not been fully elucidated. Transforming growth factor-beta1 (TGF-β1) is involved in the development of renal scarring. Apoptosis is r
Autor:
Abdel Meguid El Nahas, Florentia Sotsiou, Simon Oldroyd, Dimitrios S. Goumenos, Athanassios C. Tsamandas, John G. Vlachojannis, Dionysios Bonikos, Chrisanthi Petropoulou, Sotiris Tsakas
Publikováno v:
Nephron. 87:240-248
Background/Aims: The cellular and humoral factors involved in the development and progression of renal scarring have not been fully investigated. Transforming growth factor-β (TGF-β1) is considered to be the main fibrogenic growth factor and it is
Autor:
Pantelitsa, Kalliakmani, Eleni, Koutroulia, Florentia, Sotsiou, John G, Vlachojannis, Dimitrios S, Goumenos
Publikováno v:
Nephrology (Carlton, Vic.). 15(8)
Idiopathic membranous nephropathy (IMN), the most common cause of nephrotic syndrome in adults, is usually treated by cyclosporin A (CsA). Estimation of the effectiveness of long-term use of CsA in the remission and relapse rate of nephrotic syndrome
Autor:
Pantelitsa Kalliakmani, Dimitrios S. Goumenos, Dionisios Karavias, Evagelos Papachristou, Florentia Sotsiou, Jannis G. Vlachojannis, Dimitrios Presvelos, Irini Savidaki, Sotiria Alexandri
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 23
BackgroundLong-term exposure of peritoneal membrane to bioincompatible dialysis solutions leads to structural changes and loss of ultrafiltration capability.ObjectiveWe studied the possible relationship between histologic change and the transport cha
Autor:
Dimitrios S. Goumenos, Florentia Sotsiou, Sotiris Tsakas, John G. Vlachojannis, Pantelitsa Kalliakmani
Publikováno v:
BMC Nephrology, Vol 6, Iss 1, p 16 (2005)
BMC Nephrology
BMC Nephrology
Background Crescentic nephritis is characterized by formation of cellular crescents that soon become fibrotic and result in irreversible damage, unless an effective immunosuppressive therapy is rapidly commenced. TGF-β1 is involved in the developmen
Autor:
Florentia Sotsiou-Candila, Leonidas Christou, Konstantinos Siamopoulos, Konstantinos L. Bourantas, Eleftheria Hatzimichael
Publikováno v:
Acta haematologica. 101(4)
We report a case of a 39-year-old man with lambda-light-chain multiple myeloma, nephrotic syndrome due to lambda-light-chain deposition disease in kidneys and amyloidosis in other tissues. The patient was treated with melphalan and prednisone for 1 y